To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects
Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
GSK945237 is the first molecule of a new chemical class that is being developed for treatment
of respiratory tract and other infections such as skin and soft tissue. This study drug has
been tested in animals but has never been given to humans. This is a two part study. The
purpose of the first part is to study the side effects of this drug in humans, and to study
how much of the drug gets absorbed in the blood stream The second part of this study will
compare absorption of the study drug in the blood stream when given with food and when given
under fasting conditions